Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04462198 |
|---|---|
| Brief Title: | Phase I/IIa Study Evaluating Safety and Efficacy of an Intratympanic Dose of PIPE-505 in Subjects With Hearing Loss |
| First Submitted : | June 29, 2020 |
| First Submitted that Met QC Criteria : | July 4, 2020 |
| First Posted : | July 8, 2020 |
| Certification/Extension First Submitted : | June 7, 2022 |
| Certification/Extension First Submitted that Met QC Criteria : | June 7, 2022 |
| Certification/Extension First Posted : | June 10, 2022 |
| Last Update Submitted that Met QC Criteria : | June 7, 2022 |
| Last Update Posted : | June 10, 2022 |